Analysts at Piper Jaffray upgrade Exelixis EXEL from "neutral" to "overweight." The target price for EXEL is set to $7.
EXEL gained 0.19% to close at $5.33 yesterday. More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Posted In: EarningsLong IdeasUpgradesMarketsAnalyst RatingsTrading IdeasHealth CareLife Sciences Tools & ServicesPiper Jaffray
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in